Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iron complexes involved in Fenton chemistry, primarily represented by the labile iron pool (LIP), consist of redox-active ferrous iron (Fe2+) that catalyzes the decomposition of hydrogen peroxide into highly reactive hydroxyl radicals [1]. This process, known as the Fenton reaction, is a central driver of oxidative stress and lipid peroxidation, particularly in the context of ferroptosis, a form of regulated cell death [2]. In healthy cells, iron is strictly sequestered by proteins like ferritin and transferrin; however, pathological accumulation of labile iron occurs in conditions such as hereditary hemochromatosis, thalassemia, and various neurodegenerative disorders [3]. Therapeutic intervention typically involves the use of iron chelators, such as deferoxamine, deferiprone, or deferasirox, which bind to these iron complexes to prevent their participation in radical-generating reactions [4]. Targeting these complexes is also a burgeoning strategy in oncology, where modulating iron levels can sensitize cancer cells to ferroptotic stimuli or inhibit tumor growth [2]. Beyond chelation, research into small-molecule inhibitors of the Fenton reaction aims to mitigate ischemia-reperfusion injury and chronic inflammation [1]. Monitoring these complexes often involves measuring labile plasma iron (LPI) to assess the risk of oxidative damage in patients with iron overload [4].
Iron chelation to prevent the catalytic formation of hydroxyl radicals via the Fenton reaction
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iron(II) complexes (Labile Iron Pool) (LIP).